CD11b+ myeloid cells — encompassing granulocytic and monocytic cells as well as TAM and CD11b+ DCs — were less frequent in SI tumors from AOM-treated than untreated mice (24.1 ± 6.1 vs. 53.2 ± 7.0, mean ± SEM, p = 0.024; Figure 3A). The gene discussed is ITGAM; the disease is infectious otitis media.